Back
Moleculin Biotech Stock Price Chart
Sponsored
MBRX
Sponsored
Free 23-page book shares my #1 indicator to use
Here's the 23-page free book.
Sell
15
MBRX
Moleculin Biotech
Last Price:
2.41
Seasonality Move:
-17.51%
7 Day Trial
ALL ACCESS PASS
$
7
10 minutes on Tuesday - $1,270 by Friday?
Click here to discover how this "odd" trade could double your money each week.- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and MBRX is experiencing selling pressure, which indicates risk of future bearish movement.
Moleculin Biotech Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 2.39 | Sell |
20-day SMA: | 2.43 | Sell |
50-day SMA: | 2.81 | Sell |
200-day SMA: | 5.74 | Sell |
8-day EMA: | 2.38 | Sell |
20-day EMA: | 2.44 | Sell |
50-day EMA: | 2.81 | Sell |
200-day EMA: | 5.24 | Sell |
Moleculin Biotech Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.09 | Sell |
Relative Strength Index (14 RSI): | 40.34 | Sell |
Chaikin Money Flow: | -11199 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (2.37 - 2.51) | Sell |
Bollinger Bands (100): | (2.56 - 4.6) | Sell |
Moleculin Biotech Technical Analysis
Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Moleculin Biotech Stock
Is Moleculin Biotech Stock a Buy?
- Moleculin Biotech share price is 2.31 while MBRX 8-day simple moving average is 2.39, which is a Sell signal.
- The stock price of MBRX is 2.31 while Moleculin Biotech 20-day SMA is 2.43, which makes it a Sell.
- Moleculin Biotech 50-day simple moving average is 2.81 while MBRX share price is 2.31, making it a Sell technically.
- MBRX stock price is 2.31 and Moleculin Biotech 200-day simple moving average is 5.74, creating a Sell signal.
MBRX Technical Analysis vs Fundamental Analysis
Sell
15
Moleculin Biotech (MBRX)
is a Sell
Is Moleculin Biotech a Buy or a Sell?
-
Moleculin Biotech stock is rated a Sell
The current Moleculin Biotech [MBRX] share price is $2.31. The Score for MBRX is 15, which is 70% below its historic median score of 50, and infers higher risk than normal.
Moleculin Biotech Stock Info
Market Cap:
6.57M
Price in USD:
2.31
Share Volume:
12.68K
Moleculin Biotech 52-Week Range
52-Week High:
15.75
52-Week Low:
2.12
Sell
15
Moleculin Biotech (MBRX)
is a Sell
Moleculin Biotech Share Price Forecast
-
What is the Moleculin Biotech stock price today?
The Moleculin Biotech stock price is 2.31 USD today. -
Will MBRX stock go up or go down?
Moleculin Biotech> share price is forecast to RISE/FALL based on technical indicators -
Is Moleculin Biotech overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Moleculin Biotech is overvalued.
Is Moleculin Biotech Stock a Buy?
- Moleculin Biotech share price is 2.31 while MBRX 8-day exponential moving average is 2.38, which is a Sell signal.
- The stock price of MBRX is 2.31 while Moleculin Biotech 20-day EMA is 2.44, which makes it a Sell.
- Moleculin Biotech 50-day exponential moving average is 2.81 while MBRX share price is 2.31, making it a Sell technically.
- MBRX stock price is 2.31 and Moleculin Biotech 200-day simple moving average is 5.24, creating a Sell signal.
Fundamental Analysis of Moleculin Biotech
Is Moleculin Biotech a good investment?
- Analysts estimate an earnings increase this quarter of $2.79 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.06 per share, and an increase next year of $8.81 per share.
Technical Analysis of Moleculin Biotech
Should I short Moleculin Biotech stock?
- MBRX Moving Average Covergence Divergence (MACD) indicator is -0.09, suggesting Moleculin Biotech is a Sell
- Moleculin Biotech Relative Strength Index (RSI) is 40.34, which suggest Moleculin Biotech is oversold
- The Bollinger Bands (25) for Moleculin Biotech is (2.37 - 2.51), which suggest Moleculin Biotech is a Sell
- The Bollinger Bands (100) for Moleculin Biotech is (2.56 - 4.6), which suggest Moleculin Biotech is a Sell
* Moleculin Biotech stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.